A phase 2 trial of hydroxychloroquine in individuals at risk for rheumatoid arthritis
Background Individuals with serum elevations of anti‐cyclic citrullinated peptide (anti‐CCP) antibodies are at increased risk for future rheumatoid arthritis (RA). No pharmacologic interventions have been approved for the prevention of RA in such ‘at‐risk’ individuals. However, hydroxychloroquine (HCQ) is used without supporting clinical trial evidence.
Kevin D. Deane +33 more
wiley +1 more source
Anthrax Vaccination, Gulf War Illness, and Human Leukocyte Antigen (HLA). [PDF]
James LM +5 more
europepmc +1 more source
Allogeneic mesenchymal stromal cell therapy in kidney transplantation: should repeated human leukocyte antigen mismatches be avoided? [PDF]
Bezstarosti S +12 more
europepmc +1 more source
Genetic testing and human leukocyte antigen in patients with hypertrophic cardiomyopathy and connective tissue diseases. [PDF]
Hiraya D +4 more
europepmc +1 more source
Guidance of ganciclovir therapy with pp65 antigenemia in cytomegalovirus-free recipients of livers from seropositive donors [PDF]
Fung, J +7 more
core
A Rare Case of Ketosis-Prone Type 2 Diabetes With a Unique Human Leukocyte Antigen (HLA) Profile: Genetic and Metabolic Insights. [PDF]
Mukai M +4 more
europepmc +1 more source
Correction to "Mitogen-Activated Protein Kinase Inhibition Augments the T Cell Response Against HOXB7-Expressing Tumor Through Human Leukocyte Antigen Upregulation". [PDF]
europepmc +1 more source
Association of Human Leukocyte Antigen Alleles with COVID-19 Severity and Mortality in a Spanish Population. [PDF]
Lobato-Martinez E +8 more
europepmc +1 more source

